TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 6.93 BATS BZX Real-Time Price As of 10:23am ET |  +0.44 / +6.78%Today’s Change | 5.84 Today|||52-Week Range 21.45 | -51.47% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 6.49 |
| Today’s open | 6.90 |
| Day’s range | 6.90 - 7.12 |
| Volume | 1,568 |
| Average volume (3 months) | 93,056 |
| Market cap | $162.0M |
Data as of 10:23am ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | -314.08% |
| Earnings growth (this year) | +95.42% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNOVMediciNova Inc | +0.22 | +6.09% |
| OVIDOvid Therapeutics In... | -0.03 | -1.04% |
| BFRABiofrontera AG | 0.00 | 0.00% |
| SMMTSummit Therapeutics ... | 0.00 | 0.00% |
Data as of 10:38am ET, 03/31/2020
Financials
| Next reporting date | May 18, 2020 |
| EPS forecast (this quarter) | -$0.57 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
